New polypill increases adherence to treatment following myocardial infarction
A new polypill increases adherence to treatment following a myocardial infarction (MI), according to results from the FOCUS Study presented for the first time at ESC Congress 2014 today by principal...
View ArticleNovel polypill increases patient adherence to treatment following heart attack
New research shows a novel polypill increases patient adherence to treatment following a myocardial infarction (MI) or heart attack, according to new study results reported at the European Society of...
View ArticleNew preclinical study shows RG-012 may provide therapeutic benefit for Alport...
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that positive new preclinical data was...
View ArticleRegulus Therapeutics reports net loss of $22.2 million for fourth quarter 2014
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results for the fourth quarter and...
View ArticleNew study predicts outcomes of CV patients using polypill intervention
A new study published in the journal BMJ Open (May 2015) has demonstrated that the improved treatment adherence achievable using a fixed-dose combination polypill (atorvastatin, ramipril and low-dose...
View ArticleStudy suggests proteinuria lowering as important target in managing pediatric...
In a study of children with chronic kidney disease, blood pressure medications reduced protein excretion in the urine, which was linked with a lower risk of disease progression.
View ArticleDo ACE inhibitors increase SARS-CoV-2 binding to ACE2?
The COVID-19 pandemic has forced clinicians and academicians to intensive research to find evidence for many conventional therapies. A new round-up editorial published in the journal Cardiovascular...
View ArticleNew clinical trial to assess whether hypertension drug may reduce COVID-19...
Researchers at University of California San Diego School of Medicine have launched a clinical trial to investigate whether a drug approved for treating high blood pressure, heart failure and diabetic...
View ArticleUTHealth physicians investigate blood pressure drug's effect on improving...
An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health...
View ArticleCommon high blood pressure medications do not increase risk of depression
None of the 41 most common high blood pressure medications increased the risk of depression, while nine medications appeared to lower it, according to a study from Denmark, published today in...
View ArticlePolypill plus aspirin and polypill alone reduced cardiovascular disease risk
A single, daily pill combining blood pressure and cholesterol medications, along with the addition of a daily dose of aspirin, reduced cardiovascular disease events in people at risk for heart disease,...
View ArticleCombination of polypill and aspirin can reduce cardiovascular events by up to...
Heart attacks, strokes and other cardiovascular incidents can be cut by 20 to 40 per cent through use of a polypill which combines three blood pressure medications and a lipid lowering medication taken...
View ArticleSacubitril/valsartan drug did not significantly reduce cardiovascular death...
The heart failure drug sacubitril/valsartan did not significantly reduce the rate of heart failure or cardiovascular death following a heart attack compared to ramipril, an angiotensin-converting...
View ArticleGut bacteria can reduce the effectiveness of certain blood pressure drugs
A new study from The University of Toledo College of Medicine and Life Sciences has shown gut bacteria can reduce the effectiveness of certain blood pressure drugs.
View ArticleThree-drug medication effective in preventing recurrent cardiovascular events...
A three-drug medication known as a "polypill," developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events...
View ArticleInsights from a global study: The association between dietary patterns,...
Researchers develop a healthy diet score linked to health outcomes with global applicability using the Prospective Urban Rural Epidemiology study data.
View ArticleUromodulin levels linked to kidney failure risk
Prior studies of uromodulin, the most abundant protein in urine, and kidney disease have focused primarily on urinary uromodulin levels.
View Article